What is Garner?
Garner operates at the intersection of health care law, regulatory compliance, and strategic institutional management. In an era defined by the Affordable Care Act and frequent legislative shifts, the company provides essential guidance to hospitals, behavioral health providers, pharmacies, and clinical laboratories. By synthesizing deep historical expertise with a forward-looking approach to innovation and efficiency, Garner enables its clients to overcome day-to-day operational obstacles while maintaining strict adherence to complex federal and state regulations. The firm's market position is defined by its unique ability to translate intricate legal requirements into actionable business strategies, ensuring that providers remain resilient in a volatile health care economy.
How much funding has Garner raised?
Garner has raised a total of $280.1M across 6 funding rounds:
Seed
$4.5M
Multiple Rounds
$57.6M
Series D
$118M
Series E
$100M
Seed (2020): $4.5M, investors not publicly disclosed
Debt (2021): $60K led by PPP
Series A (2021): $12.5M, investors not publicly disclosed
Series B (2021): $45M, investors not publicly disclosed
Series D (2026): $118M backed by PLUS Capital, Kleiner Perkins, Kaiser Permanente Ventures, and Redpoint Ventures
Series E (2026): $100M with participation from Index Ventures, Redpoint Ventures, Kleiner Perkins, Sequoia, Thrive Capital, Founders Fund, and Kaiser Permanente Ventures
Key Investors in Garner
Index Ventures
A global venture firm that partners with entrepreneurs from seed to IPO, known for backing transformative companies that challenge the status quo.
Kleiner Perkins
A premier venture capital firm that invests in early and growth-stage technology and life science companies, providing operational support from inception to exit.
Kaiser Permanente Ventures
The strategic venture arm of Kaiser Permanente, focused on advancing healthcare innovation by bridging the gap between new solutions and established delivery systems.
What's next for Garner?
With the successful closure of its Series E round, Garner is well-positioned to expand its service offerings and deepen its technological integration within the health care sector. The company's strategic roadmap likely involves scaling its advisory capacity to meet the rising demand for compliance-driven innovation. By utilizing the $100M in new capital, Garner is expected to enhance its digital infrastructure and broaden its reach across the national health care delivery ecosystem. Future growth will likely focus on addressing the emerging challenges of behavioral health integration and the increasing complexity of reimbursement models, ensuring that Garner remains a cornerstone of stability and strategic foresight for its institutional clients.
See full Garner company page
